Nitrogen Containing Heterocycles as Anticancer Agents: A Medicinal Chemistry Perspective
Pharmaceuticals · 14.02.2023 · 16 (2) · 299
DOI: 10.3390/ph16020299 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 14.02.2023. Verfasst von Adarsh Kumar und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Ghudda, Bathinda 151401, India. Die Arbeit wurde bisher 388-mal zitiert (Crossref) und nennt 276 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Abdullah University of Science and Technology.
Abstract (Originalsprache)
Cancer is one of the major healthcare challenges across the globe. Several anticancer drugs are available on the market but they either lack specificity or have poor safety, severe side effects, and suffer from resistance. So, there is a dire need to develop safer and target-specific anticancer drugs. More than 85% of all physiologically active pharmaceuticals are heterocycles or contain at least one heteroatom. Nitrogen heterocycles constituting the most common heterocyclic framework. In this study, we have compiled the FDA approved heterocyclic drugs with nitrogen atoms and their pharmacological properties. Moreover, we have reported nitrogen containing heterocycles, including pyrimidine, quinolone, carbazole, pyridine, imidazole, benzimidazole, triazole, β-lactam, indole, pyrazole, quinazoline, quinoxaline, isatin, pyrrolo-benzodiazepines, and pyrido[2,3-d]pyrimidines, which are used in the treatment of different types of cancer, concurrently covering the biochemical mechanisms of action and cellular targets.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Ghudda, Bathinda 151401, India.
- Pharmacology Research Laboratory, Faculty of Pharmaceutical Sciences, Rama University, Kanpur 209217, India.
- Laboratory of Computational Modeling of Drugs, Higher Medical and Biological School, South Ural State University, 454008 Chelyabinsk, Russia.
- Bioorganic and Medicinal Chemistry Research Laboratory, Department of Pharmaceutical Sciences, Sam Higginbottom University of Agriculture, Technology and Sciences, Prayagraj 211007, India.
- Department of Pharmaceutical Chemistry and Pharmacognosy, Unaizah College of Pharmacy, Qassim University, Unayzah 51911, Saudi Arabia.
- Smart-Health Initiative and Red Sea Research Center, Division of Biological and Environmental Sciences and Engineering, King Abdullah University of Science and Technology, Thuwal 23955-6900, Saudi Arabia.
ORCID-Profile: Adarsh Kumar, Ankit Kumar Singh, Jagat Pal Yadav, Prateek Pathak, Maria Grishina, Amita Verma, Habibullah Khalilullah, Abdul-Hamid Emwas, Pradeep Kumar
Förderung
- King Abdullah University of Science and Technology
Zitieren
APA
Kumar, A., Singh, A. K., Singh, H., Vijayan, V., Kumar, D., Naik, J., Thareja, S., Yadav, J. P., Pathak, P., Grishina, M., Verma, A., Khalilullah, H., Jaremko, M., Emwas, A. H., & Kumar, P. (2023). Nitrogen Containing Heterocycles as Anticancer Agents: A Medicinal Chemistry Perspective. Pharmaceuticals, 16(2), 299. https://doi.org/10.3390/ph16020299
Vancouver
Kumar A, Singh AK, Singh H, Vijayan V, Kumar D, Naik J, et al. Nitrogen Containing Heterocycles as Anticancer Agents: A Medicinal Chemistry Perspective. Pharmaceuticals. 2023;16(2):299. doi:10.3390/ph16020299
BibTeX
@article{Kumar2023,
author = {Kumar, Adarsh and Singh, Ankit Kumar and Singh, Harshwardhan and Vijayan, Veena and Kumar, Deepak and Naik, Jashwanth and Thareja, Suresh and Yadav, Jagat Pal and Pathak, Prateek and Grishina, Maria and Verma, Amita and Khalilullah, Habibullah and Jaremko, Mariusz and Emwas, Abdul-Hamid and Kumar, Pradeep},
title = {Nitrogen Containing Heterocycles as Anticancer Agents: A Medicinal Chemistry Perspective},
journal = {Pharmaceuticals},
year = {2023},
volume = {16},
number = {2},
pages = {299},
doi = {10.3390/ph16020299}
}
EUVIMED